Y. Shiloh

885 citations
9 papers · 716 · h-index 7

Impact in

    • Carcinogens and Genotoxicity Assessment
  • Oncology top 10%
    • Cancer-related Molecular Pathways

Papers in

    • DNA Repair Mechanisms 6
    • Pluripotent Stem Cells Research 1
    • Ubiquitin and proteasome pathways 1
    • Carcinogens and Genotoxicity Assessment 4

Y. Shiloh

8 papers receiving 701 citations

Peers

Y. Shiloh
Comparison fields: 5 of 56
  • Cancer Research 272
  • Oncology 341
  • Molecular Biology 655
  • Aging 12
  • Cell Biology 64
Replace Calvina Kek with:
Calvina Kek Singapore
Yosef Shiloh Israel
Daniele Perna Italy
Thomas Schleker Switzerland
Alan D. D’Andrea United States
Marcin M. Gorski Italy
Anita Cheng United States
Deepa Shankar United States
Velibor Savic United Kingdom
Katrin Tschöp Germany
Y. Shiloh relative to Calvina Kek Singapore Calvina Kek's profile →
Citations per field
00.5×1.5×2.2×
Calvina Kek · 1×
Citations per year

Countries citing papers authored by Y. Shiloh

Since Specialization
Citations

This map shows the geographic impact of Y. Shiloh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Shiloh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Shiloh more than expected).

Fields of papers citing papers by Y. Shiloh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Shiloh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Shiloh. The network helps show where Y. Shiloh may publish in the future.

Co-authors

The 25 scholars most cited alongside Y. Shiloh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Y. Shiloh Line = papers co-authored together Y. Shiloh links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 1997402
2 1995125
3
The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress.
199767
4
Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line.
198942
5 199737
6 199520
7
In vitro phenotype of ataxia-telangiectasia (AT) fibroblast strains: clues to the nature of the "AT DNA lesion" and the molecular defect in AT.
198517
8
Enhanced phosphorylation of p53 by ATN in response to DNA damage
19985
9
RELATIVELY LOW PROPORATION OF DYSTROPHIN GENE DELETIONS IN ISRAEL DUCHENNE AND BECKER MUSCULAR DYSTROPHY PATIENTS
19941

About Y. Shiloh

Y. Shiloh is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 9 papers that have together received 716 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer-related Molecular Pathways (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Pluripotent Stem Cells Research (1 paper), Radiation Therapy and Dosimetry (1 paper), Ubiquitin and proteasome pathways (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Cancer Research (272 citations), Oncology (341 citations), Molecular Biology (655 citations), Aging (12 citations) and Cell Biology (64 citations). Y. Shiloh has collaborated with scholars based in Israel, Australia and United States. Frequent co-authors include Galit Rotman, Yael Ziv, Eynat Tabor, L. Trakhtenbrot, N.G.J. Jaspers, Tsafi Danieli, Aliza Amiel, Kum Kum Khanna, Kevin J. Spring and Jun Yan. Their work appears in journals such as Annual Review of Genetics, European Journal of Human Genetics, Journal of Biological Chemistry, Pediatric Hematology and Oncology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact